Docoh
Loading...

MLAB Mesa Laboratories

Mesa Laboratories, Inc. engages in the design, manufacture, and marketing of instruments and disposable products utilized in healthcare, pharmaceutical, food, and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection, Instruments, Cold Chain Monitoring, and Cold Chain Packaging. The Sterilization and Disinfection segment offers testing services, along with the manufacturing and marketing of biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. The Instrument segment manufactures and markets control instruments and disposable products. The Cold Chain Monitoring segment designs, develops, and markets systems which are used to monitor environmental parameters such as temperature, humidity, and differential pressure. The Cold Chain Packaging segment provides consulting services including compliance monitoring, packaging development, and validation or mapping of transport and storage containers, and thermal packaging products. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Company profile

Ticker
MLAB
Exchange
Website
CEO
Gary Owens
Employees
Incorporated
Location
Fiscal year end
Former names
MESA LABORATORIES INC /CO
SEC CIK
IRS number
840872291

MLAB stock data

(
)

Calendar

3 Feb 21
17 Apr 21
31 Mar 22
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Mar 20 Mar 19 Mar 18 Mar 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 253.73M 253.73M 253.73M 253.73M 253.73M 253.73M
Cash burn (monthly) (positive/no burn) (positive/no burn) 1.91M (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) n/a n/a 6.82M n/a n/a n/a
Cash remaining n/a n/a 246.91M n/a n/a n/a
Runway (months of cash) n/a n/a 129.3 n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
5 Apr 21 Sullivan John James Common Stock Sell Dispose S No Yes 250.76 500 125.38K 57,458
5 Apr 21 Sullivan John James Common Stock Sell Dispose S No Yes 250.76 500 125.38K 33,894
26 Mar 21 Sullivan John James Common Stock Gift Aquire G Yes No 0 23,564 0 23,564
26 Mar 21 Sullivan John James Common Stock Gift Dispose G No No 0 23,564 0 34,394
16 Mar 21 Guillemin Evan Common Stock Sell Dispose S No Yes 269.48 720 194.03K 32,035
12 Mar 21 Sakys John Common Stock Sell Dispose S No No 263.84 2,500 659.6K 4,350
12 Mar 21 Sakys John Common Stock Option exercise Aquire M No No 70.56 2,000 141.12K 6,850
12 Mar 21 Sakys John Common Stock Option exercise Aquire M No No 48.72 500 24.36K 4,850
12 Mar 21 Sakys John Non Qualified Stock Option Common Stock Dispose X No No 70.56 2,000 141.12K 32,496
12 Mar 21 Sakys John Non Qualified Stock Option Common Stock Dispose X No No 48.72 500 24.36K 34,496

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

91.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 171 149 +14.8%
Opened positions 26 7 +271.4%
Closed positions 4 23 -82.6%
Increased positions 58 82 -29.3%
Reduced positions 59 34 +73.5%
13F shares
Current Prev Q Change
Total value 1.73B 1.21B +42.7%
Total shares 4.7M 4.76M -1.4%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
BLK Blackrock 776.23K $222.5M +3.5%
Conestoga Capital Advisors 504.64K $144.65M +1.1%
Royce & Associates 307.25K $88.07M -1.0%
Vanguard 305.79K $87.65M +1.5%
IVZ Invesco 265.82K $76.2M -3.6%
TROW T. Rowe Price 261.3K $74.9M -15.2%
STT State Street 174.87K $50.13M +1.4%
Kayne Anderson Rudnick Investment Management 169.89K $48.7M +0.9%
Ranger Investment Management 164.48K $47.15M -5.0%
Artisan Partners Limited Partnership 130.89K $37.52M +2.3%
Largest transactions
Shares Bought/sold Change
GS Goldman Sachs 12.3K -64.5K -84.0%
TROW T. Rowe Price 261.3K -46.78K -15.2%
Renaissance Technologies 14.1K -28K -66.5%
BLK Blackrock 776.23K +26.26K +3.5%
Glenmede Trust Co Na 26.7K +17.87K +202.4%
JPM JPMorgan Chase & Co. 18.91K +17.14K +970.6%
Dimensional Fund Advisors 4.64K -16.56K -78.1%
R.P. Boggs & Co. Wealth Mangement 15.23K +15.23K NEW
Schroder Investment Management 109.03K +13.05K +13.6%
ATAC Neuberger Berman 1.69K -12.89K -88.4%

Financial report summary

?
Management Discussion
  • Our results of operations and period-over-period change are discussed in the following section. The tables and discussion below should be read in conjunction with the accompanying Consolidated Financial Statements and the notes thereto appearing in Item 8. Financial Statements and Supplementary Data (in thousands, except percent data).
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: AcquiredWe, Butler, capacity, comparison, depleted, Docment, examination, exceeded, expansion, experienced, fall, inconsistent, indemnified, invoiced, IRS, Jersey, jurisdiction, loosening, obsolete, preacquisition, produced, progressed, properly, reaction, recover, remit, remitted, remitting, resume, resumed, roll, subsidiary, summer, technical, tightening, unrealized, USD, vaccine, viability, weakened, weakening
Removed: allocate, budget, exclusion, fourth, innovation, lowest, omitted, prepare, recently, represented, seasonal